S&P 500   5,132.25 (-0.09%)
DOW   39,005.61 (-0.21%)
QQQ   445.06 (-0.12%)
AAPL   176.88 (-1.55%)
MSFT   413.23 (-0.55%)
META   503.50 (+0.24%)
GOOGL   135.97 (-0.85%)
AMZN   177.81 (-0.23%)
TSLA   199.52 (-1.54%)
NVDA   840.13 (+2.11%)
NIO   5.62 (-2.77%)
AMD   204.89 (+1.11%)
BABA   73.87 (-1.01%)
T   16.88 (-0.59%)
F   12.45 (+0.00%)
MU   97.96 (+2.95%)
CGC   3.24 (+0.93%)
GE   158.80 (+0.09%)
DIS   113.15 (+1.07%)
AMC   4.39 (+0.69%)
PFE   26.53 (-0.23%)
PYPL   60.60 (+0.10%)
XOM   106.26 (+0.40%)
S&P 500   5,132.25 (-0.09%)
DOW   39,005.61 (-0.21%)
QQQ   445.06 (-0.12%)
AAPL   176.88 (-1.55%)
MSFT   413.23 (-0.55%)
META   503.50 (+0.24%)
GOOGL   135.97 (-0.85%)
AMZN   177.81 (-0.23%)
TSLA   199.52 (-1.54%)
NVDA   840.13 (+2.11%)
NIO   5.62 (-2.77%)
AMD   204.89 (+1.11%)
BABA   73.87 (-1.01%)
T   16.88 (-0.59%)
F   12.45 (+0.00%)
MU   97.96 (+2.95%)
CGC   3.24 (+0.93%)
GE   158.80 (+0.09%)
DIS   113.15 (+1.07%)
AMC   4.39 (+0.69%)
PFE   26.53 (-0.23%)
PYPL   60.60 (+0.10%)
XOM   106.26 (+0.40%)
S&P 500   5,132.25 (-0.09%)
DOW   39,005.61 (-0.21%)
QQQ   445.06 (-0.12%)
AAPL   176.88 (-1.55%)
MSFT   413.23 (-0.55%)
META   503.50 (+0.24%)
GOOGL   135.97 (-0.85%)
AMZN   177.81 (-0.23%)
TSLA   199.52 (-1.54%)
NVDA   840.13 (+2.11%)
NIO   5.62 (-2.77%)
AMD   204.89 (+1.11%)
BABA   73.87 (-1.01%)
T   16.88 (-0.59%)
F   12.45 (+0.00%)
MU   97.96 (+2.95%)
CGC   3.24 (+0.93%)
GE   158.80 (+0.09%)
DIS   113.15 (+1.07%)
AMC   4.39 (+0.69%)
PFE   26.53 (-0.23%)
PYPL   60.60 (+0.10%)
XOM   106.26 (+0.40%)
S&P 500   5,132.25 (-0.09%)
DOW   39,005.61 (-0.21%)
QQQ   445.06 (-0.12%)
AAPL   176.88 (-1.55%)
MSFT   413.23 (-0.55%)
META   503.50 (+0.24%)
GOOGL   135.97 (-0.85%)
AMZN   177.81 (-0.23%)
TSLA   199.52 (-1.54%)
NVDA   840.13 (+2.11%)
NIO   5.62 (-2.77%)
AMD   204.89 (+1.11%)
BABA   73.87 (-1.01%)
T   16.88 (-0.59%)
F   12.45 (+0.00%)
MU   97.96 (+2.95%)
CGC   3.24 (+0.93%)
GE   158.80 (+0.09%)
DIS   113.15 (+1.07%)
AMC   4.39 (+0.69%)
PFE   26.53 (-0.23%)
PYPL   60.60 (+0.10%)
XOM   106.26 (+0.40%)

Alzamend Neuro (ALZN) SEC Filings & 10K Form

$0.96
+0.04 (+4.23%)
(As of 09:30 AM ET)

Recent Alzamend Neuro SEC Filings

DateFilerForm TypeView
02/02/2024
3:38 PM
Alzamend Neuro (Subject)
AULT MILTON C III (Filed by)
Form SC 13D/A
02/02/2024
3:30 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:30 PM
Alzamend Neuro (Filer)
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
4:20 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
4:21 PM
Alzamend Neuro (Subject)
AULT MILTON C III (Filed by)
Form SC 13D/A
01/09/2024
3:30 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2023
3:30 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
3:30 PM
Alzamend Neuro (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/16/2023
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2023
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2023
5:01 PM
Alzamend Neuro (Issuer)
Katzoff David J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2023
4:09 PM
Alzamend Neuro (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/08/2023
4:05 PM
Alzamend Neuro (Filer)
Form 424B5
09/01/2023
3:30 PM
Alzamend Neuro (Filer)
Form DEFA14A
08/24/2023
3:30 PM
Alzamend Neuro (Filer)
Form DEF 14A
08/16/2023
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
11:15 PM
Alzamend Neuro (Filer)
Form EFFECT
06/22/2023
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/26/2023
8:30 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
3:30 PM
Alzamend Neuro (Issuer)
Jackman Stephan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2023
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2023
3:30 PM
Alzamend Neuro (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2023
3:31 PM
Alzamend Neuro (Filer)
Form DEF 14A
03/23/2023
3:30 PM
Alzamend Neuro (Issuer)
McGrath Lynne Fahey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2023
3:30 PM
Alzamend Neuro (Issuer)
AULT MILTON C III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2023
3:30 PM
Alzamend Neuro (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ALZN) was last updated on 3/4/2024 by MarketBeat.com Staff